CL2018002123A1 - Virus de vacuna del síndrome respiratorio y reproductivo porcino - Google Patents

Virus de vacuna del síndrome respiratorio y reproductivo porcino

Info

Publication number
CL2018002123A1
CL2018002123A1 CL2018002123A CL2018002123A CL2018002123A1 CL 2018002123 A1 CL2018002123 A1 CL 2018002123A1 CL 2018002123 A CL2018002123 A CL 2018002123A CL 2018002123 A CL2018002123 A CL 2018002123A CL 2018002123 A1 CL2018002123 A1 CL 2018002123A1
Authority
CL
Chile
Prior art keywords
viruses
reproductive syndrome
swine respiratory
modified
vaccine virus
Prior art date
Application number
CL2018002123A
Other languages
English (en)
Inventor
Stephen Wu
Ying Fang
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of CL2018002123A1 publication Critical patent/CL2018002123A1/es
Priority to CL2021003211A priority Critical patent/CL2021003211A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UN VIRUS DEL SÍNDROME RESPIRATORIO Y REPRODUCTIVO PORCINO VIVO, MODIFICADO. LOS VIRUS FUERON GENÉTICAMENTE ANALIZADOS Y SELECCIONADOS CON BASE EN EL AGRUPAMIENTO FILOGENÉTICO PARA MODIFICACIÓN POR TRANSFERENCIA REPETIDA EN CULTIVO DE TEJIDOS. LOS VIRUS VIVOS, MODIFICADOS SE EVALUARON POR LA CAPACIDAD PARA PROPORCIONAR INMUNIDAD PROTECTORA A VIRUS HETERÓLOGOS. LOS VIRUS VIVOS MODIFICADOS SON ÚTILES EN VACUNAS, PARTICULARMENTE EN VACUNAS LAS CUALES PUEDEN TRANSFERIR INFECCIÓN DE CERDOS POR VIRUS HETERÓLOGOS MÚLTIPLES.
CL2018002123A 2016-02-18 2018-08-07 Virus de vacuna del síndrome respiratorio y reproductivo porcino CL2018002123A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2021003211A CL2021003211A1 (es) 2016-02-18 2021-12-02 Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662296658P 2016-02-18 2016-02-18

Publications (1)

Publication Number Publication Date
CL2018002123A1 true CL2018002123A1 (es) 2018-11-23

Family

ID=58057334

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2018002123A CL2018002123A1 (es) 2016-02-18 2018-08-07 Virus de vacuna del síndrome respiratorio y reproductivo porcino
CL2021003211A CL2021003211A1 (es) 2016-02-18 2021-12-02 Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2021003211A CL2021003211A1 (es) 2016-02-18 2021-12-02 Una cepa viva modificada, del virus del síndrome respiratorio y reproductivo porcino (prrs), vacuna que lo comprende y su uso para tratar el prrs tipo ii. (divisional solicitud no. 2123-2018)

Country Status (17)

Country Link
US (2) US10155035B2 (es)
EP (1) EP3416682A1 (es)
JP (2) JP6840159B2 (es)
KR (4) KR102553821B1 (es)
CN (1) CN108697787B (es)
AU (2) AU2017219594B2 (es)
BR (1) BR112018015912A2 (es)
CA (2) CA3081982A1 (es)
CL (2) CL2018002123A1 (es)
CO (1) CO2018008184A2 (es)
EA (1) EA201891555A1 (es)
MX (2) MX2018009956A (es)
NZ (1) NZ744054A (es)
PH (1) PH12018501750A1 (es)
SG (1) SG11201805611RA (es)
TW (2) TWI704225B (es)
WO (1) WO2017142798A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI704225B (zh) 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒
CN113151493B (zh) * 2021-04-01 2023-09-15 吉林省养蜂科学研究所（吉林省蜂产品质量管理监督站、吉林省蜜蜂遗传资源基因保护中心） 一种长白山东方蜜蜂ssr标记引物组、pcr鉴定方法以及应用
CN114292961A (zh) * 2022-01-29 2022-04-08 龙岩学院 鉴定类nadc-30毒株的实时荧光rt-pcr检测引物和探针组

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4482200A (en) * 1999-04-22 2000-11-10 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
CN103695465A (zh) * 2013-12-16 2014-04-02 中国农业科学院哈尔滨兽医研究所 猪繁殖与呼吸综合征病毒疫苗株cDNA感染性克隆及其应用
WO2015140774A1 (en) * 2014-03-21 2015-09-24 Nutech Ventures A non-naturally occuring porcine reproductive and respiratory syndrome virus (prrsv) and methods of using
TWI704225B (zh) * 2016-02-18 2020-09-11 美商益農美國公司 豬繁殖與呼吸綜合症疫苗病毒

Also Published As

Publication number Publication date
KR20200049905A (ko) 2020-05-08
SG11201805611RA (en) 2018-07-30
BR112018015912A2 (pt) 2019-01-22
EA201891555A1 (ru) 2019-01-31
TWI704225B (zh) 2020-09-11
CN108697787B (zh) 2023-01-10
MX2022008809A (es) 2022-08-11
AU2019203817B2 (en) 2020-05-21
KR102553823B1 (ko) 2023-07-07
JP6840159B2 (ja) 2021-03-10
US10155035B2 (en) 2018-12-18
US20170239343A1 (en) 2017-08-24
MX2018009956A (es) 2018-11-29
PH12018501750A1 (en) 2019-05-15
KR20220027292A (ko) 2022-03-07
AU2017219594A1 (en) 2018-07-19
KR102553821B1 (ko) 2023-07-07
CA3014615A1 (en) 2017-08-24
TW201907006A (zh) 2019-02-16
CA3081982A1 (en) 2017-08-24
JP2019505217A (ja) 2019-02-28
AU2017219594B2 (en) 2019-06-27
NZ744054A (en) 2020-03-27
TWI652347B (zh) 2019-03-01
CO2018008184A2 (es) 2018-08-21
AU2019203817A1 (en) 2019-06-20
EP3416682A1 (en) 2018-12-26
US10300126B2 (en) 2019-05-28
JP2020036593A (ja) 2020-03-12
CL2021003211A1 (es) 2022-08-05
WO2017142798A1 (en) 2017-08-24
CN108697787A (zh) 2018-10-23
TW201738374A (zh) 2017-11-01
JP7053552B2 (ja) 2022-04-12
KR20180100231A (ko) 2018-09-07
KR20200072565A (ko) 2020-06-22
US20190022208A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
CY1124254T1 (el) Μεθοδοι και συνθεσεις για την προκληση προστατευτικης ανοσιας εναντι λοιμωξης ιου της ανθρωπινης ανοσοανεπαρκειας
CY1123339T1 (el) Τρι-τμηματικοι αρεναϊοι ως φορεις εμβολιου
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
PH12018501602A1 (en) Subunit immersion vaccines for fish
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
TW201613558A (en) Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
CR20160337A (es) Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b
BR112018012642A2 (pt) vacina de calicivírus felino
CL2018002123A1 (es) Virus de vacuna del síndrome respiratorio y reproductivo porcino
CO2017001614A2 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
CO7461133A2 (es) Parvovirus 5a porcino, métodos de uso y vacuna
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
EA201991041A1 (ru) Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения
CO7461135A2 (es) Parvovirus porcino 5b, métodos de uso y vacuna
UY35418A (es) Vacuna que proporciona protección frente a diferentes Picornavirus humanos.
CL2018000253A1 (es) Respuesta inmunitaria potenciada de las especies porcinas
CL2019000405A1 (es) Vacunas virales.
BR112021026502A2 (pt) Vírus de vacina de síndrome reprodutiva e respiratória porcina
EA201992167A1 (ru) Вакцина
UA119801U (uk) Вірус-вакцина-2 проти інфекційної бурсальної хвороби птиці (хвороби гамборо) зі штаму "ум-93"
UA125934U (uk) АвіВАК-ІЕКВМ-ВАКЦИНА АСОЦІЙОВАНА ІНАКТИВОВАНА ПРОТИ НЬЮКАСЛСЬКОЇ ХВОРОБИ, ІНФЕКЦІЙНОГО БРОНХІТУ КУРЕЙ ТА СИНДРОМУ ЗНИЖЕННЯ НЕСУЧОСТІ
UA104825U (uk) Штам вірусу інфекційної бурсальної хвороби kharkiv'12
TH172458A (th) องค์ประกอบวัคซีนเพื่อการป้องกันต่อการติดเชื้อไวรัสเดงกี
CR20110469A (es) Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio